InterCure Ltd. announced the successful launch of Austria’s first flagship Cookies store in Vienna’s Neubau district.
Cookies’ unique CBD menu is now available in Europe for the first time at the flagship location. Pharmaceutical grade medical cannabis, including Cookies EU-GMP THC products, will be available to Austrian patients as regulations evolve.
Following the two companies’ successful collaboration in global pharma grade medical cannabis markets, the Vienna launch marks the start of an expansion into other European countries.
“We are proud to take another important step forward in the advancement of our successful model into Europe and to deliver on our promise to provide the highest quality and dependable cannabis products to each and every territory with a regulatory framework,” InterCure CEO Alexander Rabinovitch said. “We are thrilled to welcome Austrians and millions of tourists to the country’s first Cookies location.”
“Introducing the Cookies brand and products to Vienna is a key component of our growth strategy,” said Parker Berling, President of Cookies. “By collaborating with a global player like InterCure, we could share cannabis-based medicine from California to Europe.”